ArticleBMC nephrology2026
Hospital physicians' reasoning and information needs in the diagnosis and prevention of drug-induced acute kidney injury: a qualitative study.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAcute kidney injury (AKI) is a common and severe complication in hospitalized patients. Nephrotoxic drugs significantly contribute to AKI. Diagnosis and prevention of drug-induced AKI (d-AKI) could be improved, but little is known about its occurrence despite preventive efforts. Therefore, the objective of this study was to investigate hospital physicians’ reasoning about d-AKI and gain insight into the challenges they encounter, including identifying unmet information needs surrounding d-AKI.
methodsWe conducted semi-structured interviews with hospital physicians from diverse specialties and experience levels at one Dutch academic hospital. Two interviews were independently open coded by 3 researchers and the resulting codes/themes organized by consensus. Using the resulting code tree, we conducted thematic analysis of the interviews.
resultsThirteen interviews were conducted (6 women, 7 men), with physicians’ professional experience ranging from 3 to 36 years. The group comprised 9 specialists and 4 residents. For many of these physicians, managing AKI takes priority over diagnosing d-AKI. AKI cases with multifactorial etiology and limited d-AKI awareness were mentioned as reasons for delay in or lack of d-AKI diagnosis. Physicians emphasized monitoring and risk assessment with regards to d-AKI prevention. While kidney function is generally well-monitored during hospitalization, there are circumstances where the urgency of treatment may result in less weight on nephrotoxic potential. Physicians expressed the need for an up-to-date home medication overview, monitoring guidance around nephrotoxic drugs, and better prediction of d-AKI.
conclusionThis study highlights key aspects of current hospital practices surrounding d-AKI. Diagnosing d-AKI often has a low priority, which may explain why it is often underdiagnosed and not registered. Prevention is limited by gaps in monitoring and the need for nephrotoxic drugs in urgent situations. We emphasize the need for improved d-AKI diagnosis and clinical awareness, and providing personalized d-AKI prevention strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.